Abstract
Hypertension is a major risk factor for a number of cardiovascular diseases. Proper management of hypertension may require both pharmacological and non-pharmacological interventions. Non-pharmacological interventions help reduce the daily dose of antihypertensive medication and delay the progression from prehypertension to hypertension stage. Non-pharmacological interventions include lifestyle modifications like dietary modifications, exercise, avoiding stress, and minimizing alcohol consumption. Nutritional requirements of hypertensive individuals can be addressed through adopting either the DASH diet or through traditional Mediterranean diet. These dietary guidelines promote the consumption of fruits, vegetables, grains, dairy products, and food rich in K+, Mg+2, Ca+2, and phosphorus. Restriction of Na+ intake has the greatest role in lowering the blood pressure. The DASH diet alone has the effect equal to that of a single drug therapy. After dietary modifications, exercise and weight loss are the second major intervention for hypertension management. Avoiding stressful lifestyle, depression, and anxiety also help to reduce elevated blood pressure. Minimizing alcohol intake also favors the blood pressure reduction. However, lifestyle modification is a dynamic process and requires continuous adherence. It is a multi-factorial approach targeting more than one intervention. However, 6–12-month lifestyle modifications can be attempted in stage-1 hypertensive patients without any cardiovascular complication, in the hope that they may be sufficiently effective to make it unnecessary to use medicines.
Similar content being viewed by others
References
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Abate KH, Akinyemiju TF (2017) Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA 317(2):165–182
Council ES, Redon J, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Coca A, Olsen MH, Schmieder RE (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J 34:2159–2219
Selçuk KT, Çevik C, Mercan Y, Koca H (2017) Hypertensive patients’ adherence to pharmacological and non-pharmacological treatment methods, in Turkey. IJCMPH 4(8):2648–2657
Baena CP, Olandoski M, Younge JO, Buitrago-Lopez A, Darweesh SK, Campos N, Sedaghat S, Sajjad A, van Herpt TT, Freak-Poli R (2014) Effects of lifestyle-related interventions on blood pressure in low and middle-income countries: systematic review and meta-analysis. J Hypertens 32(5):961–973
Whelton PK, Appel L, Charleston J, Dalcin AT, Ewart C, Fried L, Kaidy D, Klag MJ, Kumanyika S, Steffen L (1992) The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the trials of hypertension prevention, phase I. JAMA 267(9):1213–1220
Azadbakht L, Fard NRP, Karimi M, Baghaei MH, Surkan PJ, Rahimi M, Esmaillzadeh A, Willett WC (2011) Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients. Diabetes Care 34(1):55–57
Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM (2006) Dietary approaches to prevent and treat hypertension. Hypertension 47(2):296–308
Saneei P, Salehi-Abargouei A, Esmaillzadeh A, Azadbakht L (2014) Influence of Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure: a systematic review and meta-analysis on randomized controlled trials. Nutr Metab Cardiovasc Dis 24(12):1253–1261
Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM (1999) Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 159(3):285–293
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM (1997) A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336(16):1117–1124
Gay HC, Rao SG, Vaccarino V, Ali MK (2016) Effects of different dietary interventions on blood pressure. Hypertension HYPERTENSIONAHA 115.06853
Molitor J, Brown IJ, Chan Q, Papathomas M, Liverani S, Molitor N, Richardson S, Van Horn L, Daviglus ML, Dyer A (2014) Blood pressure differences associated with OMNIHEART-like diet compared to a typical American diet. Hypertension 64(6):1198–1204
Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM (2005) Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. Jama 294(19):2455–2464
Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin P-H, Caccia C, Johnson J, Waugh R, Sherwood A (2010) Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 170(2):126–135
Trichopoulou A, Lagiou P (1997) Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle. Nutr Rev 55(11):383–389
Núñez-Córdoba JM, Valencia-Serrano F, Toledo E, Alonso A, Martínez-González MA (2008) The Mediterranean diet and incidence of hypertension: the Seguimiento Universidad de Navarra (SUN) Study. Am J Epidemiol 169(3):339–346
Kastorini C-M, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB (2011) The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 57(11):1299–1313
Simon G (2004) Pathogenesis of structural vascular changes in hypertension. J Hypertens 22(1):3–10
Van Horn L (2015) Dietary sodium and blood pressure: how low should we go? Prog Cardiovasc Dis 58(1):61–68
Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK (2007) Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334(7599):885
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 344(1):3–10
Krishna GG, Miller E, Kapoor S (1989) Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 320(18):1177–1182
Morris RC, Sebastian A, Forman A, Tanaka M, Schmidlin O (1999) Normotensive salt sensitivity. Hypertension 33(1):18–23
Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ (1997) Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 277(20):1624–1632
Geleijnse JM, Kok FJ, Grobbee DE (2003) Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 17(7):471–480
Grimm RH Jr, Neaton JD, Elmer PJ, Svendsen KH, Levin J, Segal M, Holland L, Witte LJ, Clearman DR, Kofron P (1990) The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med 322(9):569–574
Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ (1992) A prospective study of nutritional factors and hypertension among US men. Circulation 86(5):1475–1484
Tang H, Zhang X, Zhang J, Li Y, Del Gobbo LC, Zhai S, Song Y (2016) Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials. Diabetologia 59(12):2546–2551
Witteman JC, Willett WC, Stampfer MJ, Colditz GA, Sacks FM, Speizer FE, Rosner B, Hennekens CH (1989) A prospective study of nutritional factors and hypertension among US women. Circulation 80(5):1320–1327
Dyckner T, Wester P (1983) Effect of magnesium on blood pressure. Br Med J (Clin Res Ed) 286(6381):1847–1849
Lind L, Lithell H, Pollare T, Ljunghall S (1991) Blood pressure response during long-term treatment with magnesium is dependent on magnesium status: a double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Am J Hypertens 4(8):674–679
van Mierlo LA, Arends LR, Streppel MT, Zeegers M, Kok FJ, Grobbee DE, Geleijnse JM (2006) Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 20(8):571–580
Yagi S, Aihara K-i, Kondo T, Endo I, Hotchi J, Ise T, Iwase T, Akaike M, Matsumoto T, Sata M (2014) High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients. Endocr J 61(7):727–733
Park J, Lee J-S, Kim J (2010) Relationship between dietary sodium, potassium, and calcium, anthropometric indexes, and blood pressure in young and middle aged Korean adults. NRP 4(2):155–162
Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L (2010) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev, 8 (8)
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4):503–511
Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49(5):1063–1069
Chitalia N, Recio-Mayoral A, Kaski JC, Banerjee D (2012) Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 220(1):265–268
Zhang Q-Y, Jiang C-M, Sun C, Tang T-F, Jin B, Cao D-W, He J-S, Zhang M (2015) Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease. J Nephrol 28(4):471–476
Witham M, Dove F, Dryburgh M, Sugden J, Morris A, Struthers A (2010) The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53(10):2112–2119
Sugden J, Davies J, Witham M, Morris A, Struthers A (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25(3):320–325
Witham MD, Ireland S, Houston JG, Gandy SJ, Waugh S, MacDonald TM, Mackenzie IS, Struthers AD (2014) Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 63(4):706–712
Scragg R, Slow S, Stewart AW, Jennings LC, Chambers ST, Priest PC, Florkowski CM, Camargo CA Jr, Murdoch DR (2014) Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial. Hypertension 64(4):725–730
Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KM (2013) Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61(4):779–785
Alderman MH (1994) Non-pharmacological treatment of hypertension. Lancet 344(8918):307–311
Puddey IB, Beilin LJ, Vandongen R (1987) Regular alcohol use raises blood pressure in treated hypertensive subjects: a randomised controlled trial. Lancet 329(8534):647–651
Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK (2001) Effects of alcohol reduction on blood pressure. Hypertension 38(5):1112–1117
Ohira T, Tanigawa T, Tabata M, Imano H, Kitamura A, Kiyama M, Sato S, Okamura T, Cui R, Koike KA (2009) Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension 53(1):13–19
Abramson JL, Lewis C, Murrah NV (2010) Relationship of self-reported alcohol consumption to ambulatory blood pressure in a sample of healthy adults. Am J Hypertens 23(9):994–999
Roerecke M et al (2014) The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. The Lancet Public Health 2.2:e108–e120
Arkwright PD, Beilin LJ, Rouse I, Armstrong BK, Vandongen R (1982) Effects of alcohol use and other aspects of lifestyle on blood pressure levels and prevalence of hypertension in a working population. Circulation 66(1):60–66
Nanchahal K, Ashton WD, Wood DA (2000) Alcohol consumption, metabolic cardiovascular risk factors and hypertension in women. Int J Epidemiol 29(1):57–64
Cushman WC, Cutler JA, Hanna E, Bingham SF, Follmann D, Harford T, Dubbert P, Allender PS, Dufour M, Collins JF (1998) Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med 158(11):1197–1207
Aygen B (2015) Effects of alcohol consumption on hypertension. Turgut Özal Tıp Merkezi Dergisi, 22 (2)
Faselis C, Doumas M, Kokkinos JP, Panagiotakos D, Kheirbek R, Sheriff HM, Hare K, Papademetriou V, Fletcher R, Kokkinos P (2012) Exercise capacity and progression from prehypertension to hypertension novelty and significance. Hypertension 60(2):333–338
Whelton SP, Chin A, Xin X, He J (2002) Effect of aerobic exercise on blood pressurea meta-analysis of randomized, controlled trials. Ann Intern Med 136(7):493–503
Cornelissen VA, Fagard RH, Coeckelberghs E, Vanhees L (2011) Impact of resistance training on blood pressure and other cardiovascular risk factors. Hypertension, HYPERTENSIONAHA. 111.177071
Pescatello LS, Kulikowich JM (2001) The aftereffects of dynamic exercise on ambulatory blood pressure. Med Sci Sports Exerc 33(11):1855–1861
Kelley GA, Kelley KS (2000) Progressive resistance exercise and resting blood pressure. Hypertension 35(3):838–843
Zago AS, Silveira LR, Kokubun E (2010) Effects of aerobic exercise on the blood pressure, oxidative stress and eNOS gene polymorphism in pre-hypertensive older people. Eur J Appl Physiol 110(4):825–832
Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S (1998) Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 279(11):839–846
Group, T. o. H. P. C. R (1997) Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in over-weight people with high normal blood pressure: the trials of hypertension prevention, phase II. Arch Intern Med 157:657–667
Miller ER, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ (2002) Results of the diet, exercise, and weight loss intervention trial (DEW-IT). Hypertension 40(5):612–618
Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin P-H, Svetkey LP (2003) Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA
Sparrenberger F, Cichelero F, Ascoli A, Fonseca F, Weiss G, Berwanger O, Fuchs S, Moreira L, Fuchs F (2009) Does psychosocial stress cause hypertension? A systematic review of observational studies. J Hum Hypertens 23(1):12–19
Caspi A, Harrington H, Moffitt TE, Milne BJ, Poulton R (2006) Socially isolated children 20 years later: risk of cardiovascular disease. Arch Pediatr Adolesc Med 160(8):805–811
Riley EH, Wright RJ, Jun H-J, Hibert EN, Rich-Edwards JW (2010) Hypertension in adult survivors of child abuse: observations from the Nurses’ Health Study II. J Epidemiol Community Health 64(5):413–418
Malzberg B (1937) Mortality among patients with involution melancholia. Am J Psychiatr 93(5):1231–1238
Leor J, Poole WK, Kloner RA (1996) Sudden cardiac death triggered by an earthquake. N Engl J Med 334(7):413–419
Wilbert-Lampen U, Leistner D, Greven S, Pohl T, Sper S, Völker C, Güthlin D, Plasse A, Knez A, Küchenhoff H (2008) Cardiovascular events during World Cup soccer. N Engl J Med 358(5):475–483
Grassi G (2009) Assessment of sympathetic cardiovascular drive in human hypertension. Hypertension 54(4):690–697
Jonatan YE, Widayanti JR (2017) 61 The Association of Hypertension with Depression, Anxiety and Stress Score in Atma Jaya Hospital. J Hypertens 35:e9
Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CVS (2014) Clinical practice guidelines for the management of hypertension in the community. J Clin Hypertens 16(1):14–26
Pimenta E, Oparil S (2010) Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol 6(1):21–30
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Mahmood, S., Shah, K.U., Khan, T.M. et al. Non-pharmacological management of hypertension: in the light of current research. Ir J Med Sci 188, 437–452 (2019). https://doi.org/10.1007/s11845-018-1889-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-018-1889-8